Join Tampa General Hospital in their webinar: The State of COVID. What you need to know about COVID-19 in Florida. Get your questions answered.
John Couris, CEO Jason Wilson, MD, MA, FACEP
JOHN COURIS, CEO
John D. Couris is the president and CEO of Tampa General Hospital, a nationally recognized, not-for-profit, academic and research health system. As a visionary leader in the health care industry, Couris is known for creating a professional culture that thrives on authenticity, kindness, and transparency. He believes that focusing on the well-being of his team drives positive experiences for patients.
Under Couris' leadership, Tampa General has expanded to the East Coast of Florida. The hospital opened Tampa General Hospital Cancer Institute in May 2020. With two locations in Palm Beach County, residents can now receive world-class cancer treatment and services with hometown convenience. Couris plans to continue Tampa General's expansion across the state by building relationships with additional local physicians to provide comprehensive treatment options across multiple specialties.
JASON WILSON, MD, MA, FACEP
Prior to joining Tampa General Hospital, Couris served as president and CEO of Jupiter Medical Center in Jupiter, Florida. During his time there, he forged partnerships with notable institutions, including Mount Sinai Hospital in New York and Nicklaus Children's Hospital in Miami.
Couris is the recipient of multiple awards, including being named to Florida Trend's "Florida 500" list of most influential business leaders in the state. He is a graduate of Boston University and holds a Master of Science in Management from Lesley University in Cambridge, Massachusetts.
Dr. Wilson is an emergency medicine physician. He serves as the medical director of the Clinical Decision Unit at Tampa General Hospital as well as the associate director of the Adult Emergency Department. Dr. Wilson is the research director for the USF Emergency Medicine Residency Program and for the Department of Internal Medicine Clinical Trials at Tampa General Hospital. He has developed an ED-based opioid substitution treatment program as well as a co-located hepatitis C and opioid treatment pathway with multiple community partners. He is the site principal investigator of a National Institute on Drug Abuse grant comparing different strategies of opioid withdrawal stabilization in the emergency department.